Results 81 to 90 of about 85,355 (254)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ

open access: yesClinics, 2013
OBJECTIVES: Biological markers that predict the development of invasive breast cancer are needed to improve personalized therapy for patients diagnosed with ductal carcinoma in situ.
Fernando N. Aguiar   +4 more
doaj  

Overdiagnosis due to screening mammography for women aged 40 years and over [PDF]

open access: yes, 2018
This is a protocol for a Cochrane Review. The objective was to assess the effect of screening mammography for breast cancer on overdiagnosis in women aged 40 years and older at average risk of breast ...
Barratt, Alexandra   +5 more
core   +2 more sources

Ductal Carcinoma In Situ

open access: yes, 2014
Ductal carcinoma in situ is a malignant proliferation of epithelial cells within the ducts with no invasion. DCIS (ductal carcinoma in situ) is a heterogenous group of lesions that have very different morphology, biology, and clinical behavior. It is considered to be a true precursor of invasive disease although not all DCIS progress to become invasive
  +4 more sources

A new subtype of papillary ductal carcinoma in situ with tall cell and reversed polarity morphology: a rare case report

open access: yesBMC Women's Health
Background According to previous studies, tall cell carcinoma with reversed polarity can be easily distinguished from ductal carcinoma in situ based on the absence of myoepithelium and a typical histologic feature.
Ruiqi Zhong   +3 more
doaj   +1 more source

Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND:We aimed to develop a multivariable model for prediction of underestimated invasiveness in women with ductal carcinoma in situ at stereotactic large core needle biopsy, that can be used to select patients for sentinel node biopsy at primary ...
Suzanne C E Diepstraten   +6 more
doaj   +1 more source

Breast cancer in Malta : a comparative study between the year 2000 and 2010 [PDF]

open access: yes, 2013
Introduction: During the last decade, Malta experienced the introduction of a number of programmes and initiatives aiming to raise risk and cancer awareness on breast cancer.
Caruana Dingli, Gordon, Caruana, Mandy
core  

A taxonomy of epithelial human cancer and their metastases [PDF]

open access: yes, 2009
Background: Microarray technology has allowed to molecularly characterize many different cancer sites. This technology has the potential to individualize therapy and to discover new drug targets.
Olivier Gevaert   +76 more
core   +3 more sources

Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom)

open access: yesInternational Journal of Cancer, EarlyView.
An early first pregnancy is protective against postmenopausal breast cancer. However, pregnancy is also a key contributor to weight gain, and adult weight gain increases postmenopausal breast cancer risk. This prospective cohort study quantified the combined effect of adult weight gain and age at first pregnancy on postmenopausal breast cancer risk ...
Lee Malcomson   +7 more
wiley   +1 more source

Case Report: Ductal Carcinoma in Situ Within A Granulomatous Mastitis

open access: yesEuropean Journal of Breast Health, 2018
Granulomatous lobular mastitis is a rare chronic breast disease, firstly described by Kessler and Wolloch in 1972. In this article we present a 35-yearold patient with granulomatous lobular mastitis and in situ ductal carcinoma and discuss ...
Mine Özşen   +2 more
doaj   +1 more source

The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer

open access: yesInternational Journal of Cancer, EarlyView.
Neoadjuvant endocrine therapy (NET) can help prevent metastases and improve survival in patients with hormone receptor‐positive (HR+) breast cancer. Identifying which HR+ patients will benefit from NET, however, remains challenging. Here, in a patient cohort in the Netherlands, the authors evaluated tumor‐stroma ratio (TSR) and magnetic resonance ...
Layla Andour   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy